NEFL and myeloid sarcoma: On the contrary, other studies failed to show a correlation between CSF NfL, disease progression, and the risk of conversion to SPMS.29-31 Cerebrospinal fluid NfL appears to be a potential biomarker for neuronal damage and clinical progression in MS; nonetheless, more studies are still needed in this area.